Search: (LAR1:lu) srt2:(2005-2009) mspu:(article) spr:eng lar1:(liu) >
Erythropoietin ther...
Erythropoietin therapy and cancer related anaemia : updated Swedish recommendations
-
- Ahlqvist-Rastad, Jane (author)
- Medical Products Agency, Uppsala, Sweden
-
- Albertsson, Maria (author)
- Karolinska University Hospital, Stockholm, Sweden
-
- Bergh, Jonas (author)
- Karolinska Institutet
-
show more...
-
- Birgegård, Gunnar, 1944- (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Hematologi,Uppsala University Hospital, Uppsala, Sweden
-
- Johansson, Peter (author)
- Sahlgrenska University Hospital, Gothenborg, Sweden
-
- Jonsson, Bertil (author)
- Medical Products Agency, Uppsala, Sweden
-
- Kjellén, Elisabeth (author)
- Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Påhlman, Sven (author)
- Malmö University Hospital MAS, Sweden
-
- Zackrisson, Björn (author)
- Umeå universitet,Onkologi,University Hospital of Northern Sweden, Umeå, Sweden
-
- Österborg, Anders (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2007-07-03
- 2007
- English.
-
In: Medical Oncology. - : Springer Science and Business Media LLC. - 1357-0560 .- 1559-131X. ; 24:3, s. 267-272
- Related links:
-
http://humanapress.c...
-
show more...
-
http://dx.doi.org/10...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
http://kipublication...
-
https://lup.lub.lu.s...
-
show less...
Abstract
Subject headings
Close
- Due to concerns related to treatment with erythropoietin (EPO) and possible negative effects on tumour control, a workshop was organised by the Medical Products Agency of Sweden with the aim to revise national treatment guidelines if needed. In patients with solid tumours, conflicting results have been reported with respect to tumour control and survival. Until further notice it is therefore recommended that EPO should be used restrictively in the treatment of patients with cancer and that the anticipated improvement in quality of life should be evaluated against potential risks.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Anemia
- Cancer therapy
- Epoetin
- Erythropoietin
- Erythropoietin receptor
- Safety
- MEDICINE
- MEDICIN
- erythropoietin
- safety
- cancer therapy
- epoetin
- anemia
- receptor
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Ahlqvist-Rastad, ...
-
Albertsson, Mari ...
-
Bergh, Jonas
-
Birgegård, Gunna ...
-
Johansson, Peter
-
Jonsson, Bertil
-
show more...
-
Kjellén, Elisabe ...
-
Påhlman, Sven
-
Zackrisson, Björ ...
-
Österborg, Ander ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Medical Oncology
- By the university
-
Uppsala University
-
Umeå University
-
Linköping University
-
Karolinska Institutet
-
Lund University